Literature DB >> 11432890

Late medical complications and fatigue in Hodgkin's disease survivors.

H Knobel1, J Håvard Loge, M B Lund, K Forfang, O Nome, S Kaasa.   

Abstract

PURPOSE: Long-term medical complications, such as cardiac, pulmonary, and thyroid dysfunction, are frequent among Hodgkin's disease survivors (HDSs). Chronic fatigue is also highly prevalent among HDSs. Few studies have explored possible etiologic explanations for fatigue. The aim of this study was to explore whether late cardiac, pulmonary, and thyroid complications after curative treatment for Hodgkin's disease (HD) may explain the high level of fatigue among HDSs. PATIENTS AND METHODS: Four-hundred fifty-nine patients treated for HD at the Norwegian Radium Hospital from 1971 to 1991 were included in a cross-sectional, follow-up study of subjective health status. Fatigue (physical [PF] and mental), was measured by the Fatigue Questionnaire. A subcohort of the HDSs (116 patients) treated from 1980 to 1988 were included in a separate study in which long-term cardiac, pulmonary, and thyroid complications were assessed. All patients had received radiotherapy, and 63 patients had received additional chemotherapy. The present study comprised 92 patients (mean age, 37 years; range, 23 to 56 years) who participated in both studies.
RESULTS: HDSs with pulmonary dysfunction were more fatigued than HDSs with normal pulmonary function (PF 10.9 v 8.9; P <.05). Gas transfer impairment was the most prevalent pulmonary dysfunction, and three times as many patients with gas transfer impairment reported chronic fatigue (duration, 6 months or longer), compared with patients without pulmonary dysfunction (48% v 17%, P <.01). No associations were found between cardiac sequelae or hypothyroidism and fatigue.
CONCLUSION: Pulmonary dysfunction is associated with fatigue in HDSs. Cardiac sequelae was not associated with fatigue in HDSs. We question the absence of an association between thyroid complications and fatigue.

Entities:  

Mesh:

Year:  2001        PMID: 11432890     DOI: 10.1200/JCO.2001.19.13.3226

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  24 in total

Review 1.  State-of-the-art issues in Hodgkin's lymphoma survivorship.

Authors:  Shrujal S Baxi; Matthew J Matasar
Journal:  Curr Oncol Rep       Date:  2010-11       Impact factor: 5.075

Review 2.  Late effects of therapy for Hodgkin's lymphoma.

Authors:  Michael Jacob Adams; Louis S Constine; Steven E Lipshultz
Journal:  Curr Hematol Malig Rep       Date:  2007-07       Impact factor: 3.952

3.  Cancer-related fatigue and associated disability in post-treatment cancer survivors.

Authors:  Jennifer M Jones; Karin Olson; Pamela Catton; Charles N Catton; Neil E Fleshner; Monika K Krzyzanowska; David R McCready; Rebecca K S Wong; Haiyan Jiang; Doris Howell
Journal:  J Cancer Surviv       Date:  2015-04-16       Impact factor: 4.442

4.  A high level of fatigue among long-term survivors of non-Hodgkin's lymphoma: results from the longitudinal population-based PROFILES registry in the south of the Netherlands.

Authors:  Simone Oerlemans; Floortje Mols; Djamila E Issa; J H F M Pruijt; Wim G Peters; Marnix Lybeert; Wobbe Zijlstra; Jan Willem W Coebergh; Lonneke V van de Poll-Franse
Journal:  Haematologica       Date:  2012-08-28       Impact factor: 9.941

5.  Doxorubicin acts via mitochondrial ROS to stimulate catabolism in C2C12 myotubes.

Authors:  Laura A A Gilliam; Jennifer S Moylan; Elaine W Patterson; Jeffrey D Smith; Anne S Wilson; Zaheen Rabbani; Michael B Reid
Journal:  Am J Physiol Cell Physiol       Date:  2011-09-21       Impact factor: 4.249

6.  A Single Center Survey of Health-Related Quality of Life among Acute Myeloid Leukemia Survivors in First Complete Remission.

Authors:  M Jennifer Cheng; B Douglas Smith; Christopher S Hourigan; Ivana Gojo; Keith W Pratz; Amanda L Blackford; Ambereen K Mehta; Thomas J Smith
Journal:  J Palliat Med       Date:  2017-05-24       Impact factor: 2.947

Review 7.  Care of the adult Hodgkin lymphoma survivor.

Authors:  Carrie A Thompson; Karen Mauck; Rachel Havyer; Anjali Bhagra; Henna Kalsi; Sharonne N Hayes
Journal:  Am J Med       Date:  2011-12       Impact factor: 4.965

8.  Cancer-Related Fatigue, Version 2.2015.

Authors:  Ann M Berger; Kathi Mooney; Amy Alvarez-Perez; William S Breitbart; Kristen M Carpenter; David Cella; Charles Cleeland; Efrat Dotan; Mario A Eisenberger; Carmen P Escalante; Paul B Jacobsen; Catherine Jankowski; Thomas LeBlanc; Jennifer A Ligibel; Elizabeth Trice Loggers; Belinda Mandrell; Barbara A Murphy; Oxana Palesh; William F Pirl; Steven C Plaxe; Michelle B Riba; Hope S Rugo; Carolina Salvador; Lynne I Wagner; Nina D Wagner-Johnston; Finly J Zachariah; Mary Anne Bergman; Courtney Smith
Journal:  J Natl Compr Canc Netw       Date:  2015-08       Impact factor: 11.908

Review 9.  Cancer-related fatigue: the approach and treatment.

Authors:  Carmen P Escalante; Ellen F Manzullo
Journal:  J Gen Intern Med       Date:  2009-11       Impact factor: 5.128

10.  Fatigue in patients with adjuvant radiation therapy for breast cancer: long-term follow-up.

Authors:  Hans Geinitz; Frank B Zimmermann; Reinhard Thamm; Monika Keller; Raymonde Busch; Michael Molls
Journal:  J Cancer Res Clin Oncol       Date:  2004-03-06       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.